Armistice Capital »

Allarity Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Allarity Therapeutics (ALLR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Allarity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allarity Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allarity Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $195k 261k 0.75

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Allarity Therapeutics

Two Sigma Securities
Virtu Financial
Wells Fargo & Company

View all funds holding Allarity Therapeutics